Loerop James
CIK 0001781549
Chief Business Officer
Filings
13
Latest Feb 6, 2026
Issuers covered
1
Showing
13 of 13
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +21.7% | +21.7% | +42.5% | +0.9% |
| 90 days | 2 | 50% | -23.6% | -23.6% | +39.7% | -86.8% |
| 180 days | 2 | 50% | -24.1% | -24.1% | +33.4% | -81.7% |
| 365 days | 2 | 50% | +4.7% | +4.7% | +91.4% | -82.0% |
Issuers
Companies where Loerop James has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 13 | Feb 6, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|